Back

Results - Announcements

Sales rise 5.39% to Rs 18.37 crore

Sandu Pharmaceuticals standalone net profit rises 166.67% in the December 2024 quarter

14-Feb-2025, 07:49
Net profit of Sandu Pharmaceuticals rose 166.67% to Rs 0.56 crore in the quarter ended December 2024 as against Rs 0.21 crore during the previous quarter ended December 2023. Sales rose 5.39% to Rs 18.37 crore in the quarter ended December 2024 as against Rs 17.43 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	18.37	17.43	5
OPM %	5.44	2.93	-
PBDT	0.99	0.52	90
PBT	0.80	0.38	111
NP	0.56	0.21	167